WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 34'2271 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 4'506  4'460  4'414  4'368  4'323  3'858  3'398  3'147 
Births 62  63  63  63  63  56  57  51 
Surviving infants 62  62  63  63  63  55  57  50 
Pop. less than 5 years 318  321  319  312  308  283  277  257 
Pop. less than 15 years 911  907  902  895  894  877  790  856 
Female 15-49 years 1'086  1'086  1'085  1'084  1'080  991  900  772 

Number of reported case

(Click for retrospective incidence data for New Zealand)
Diphtheria 20 
Japanese encephalitis
Measles 68  597  43  198  65 
Mumps 23  26  52  14  21  50 
Pertussis 3'396  5'598  1'992  462  656  4'143  91 
Polio*
Rubella 22  26 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for New Zealand)
Vaccine year result method % card seen                                                
BCG          20 
DTP1          93  94  95  95  94  89 
DTP3          92  93  95  93  92  90  90  76 
HepB_BD          89 
HepB3          93  93  95  90  93  90 
Hib3          92  93  94  89  98  90 
JapEnc         
MCV          92  92  93  91  89  85  90  80 
MCV2          86  85  86 
PCV1          94  93  94  90  90 
PCV3          93  92  92  89  87 
Pol3          92  93  95  93  92  82 
Rota1         
Rota_last         
Rubella1          92  93 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for New Zealand)
DTP1 93  94  95  95  94  96  96  91 
DTP3 92  93  95  93  92  90  90  76 
HepB3 93  93  95  90  93  90 
HepB_BD
Hib3 92  93  94  89  98  90 
MCV 92  92  93  91  89  85  90  80 
MCV2 86  85  86 
PnC3 93  92  92  89  87 
Pol3 92  93  95  93  92  82  90 
Rota_last

Number of districts in the country 20  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG Yes Babies and children under 5 years who are at high risk of TB and specific individuals as result of TB contact tracing
DTaPHibHepIPV 6 weeks; 3, 5 months; Yes
DTaPIPV 4 years; Yes
HPV 12 years; Yes
HepA Yes for eligible individuals
HepB Yes babies of HBsAg positive mothers, high risk and unimmunised children and adults at risk
Hib 15 months; Yes individals pre and post splenectomy
IPV Yes high risk
Influenza <18 years; > 64 years; Yes All children under 18 years for one Health District and all other ages with chronic medical conditions and Pregnant women
MMR 15 months; 4 years; Yes unimmunized individuals
MenACWY Yes individuals pre and post splenectomy
MenC_conj Yes From July 2014
Pneumo_conj 6 weeks; 3, 5, 15 months; Yes 10 valent on National Immunisation Schedule and 13 valent offered to high risk children under 5 years
Pneumo_ps Yes high risk children and pre and post splenectomy
Rotavirus 6 weeks; 3, 5 months; Yes From July 2014
Td 45, 65 years; Yes also for wound management and catch up programmes
Tdap 11 years; Yes also offered to pregnant women 28-38 weeks gestation during current pertussis outbreak
Zoster Yes From July 2014

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes    No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number 20  20           

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 20  20  20  20       
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100%      
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes    Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100    100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.